Literature DB >> 17102154

Practical review of oral antihyperglycemic agents for type 2 diabetes mellitus.

Renee Rae Koski1.   

Abstract

This article gives a practical review of the pharmacology, clinical efficacy, safety, dosing, cost, and place in therapy for oral antihyperglycemic agents used in the treatment of type 2 diabetes mellitus. There are 5 classes of oral antihyperglycemic agents available in the United States: sulfonylurea secretagogues, biguanides, alpha-glucosidase inhibitors, thiazolidinediones, and nonsulfonylurea secretagogues. These agents have distinct characteristics that help in their selection for the treatment of type 2 diabetes.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17102154     DOI： 10.1177/0145721706294260

Source DB:  PubMed          Journal:  Diabetes Educ        ISSN： 0145-7217            Impact factor:   2.140


  8 in total

1.  Opuntia dillenii (Ker Gawl.) Haw., Seeds Oil Antidiabetic Potential Using In Vivo, In Vitro, In Situ, and Ex Vivo Approaches to Reveal Its Underlying Mechanism of Action.

Authors:  Mohamed Bouhrim; Hayat Ouassou; Salima Boutahiri; Nour Elhouda Daoudi; Hamza Mechchate; Bernard Gressier; Bruno Eto; Hamada Imtara; Amal A Alotaibi; Mohammed Al-Zharani; Abderrahim Ziyyat; Hassane Mekhfi; Abdelkhaleq Legssyer; Mohammed Aziz; Mohamed Bnouham
Journal:  Molecules       Date:  2021-03-17       Impact factor: 4.411

Review 2.  Noninsulin glucose-lowering agents for the treatment of patients on dialysis.

Authors:  Colleen Flynn; George L Bakris
Journal:  Nat Rev Nephrol       Date:  2013-01-29       Impact factor: 28.314

3.  Gynostemma pentaphyllum Tea Improves Insulin Sensitivity in Type 2 Diabetic Patients.

Authors:  V T T Huyen; D V Phan; P Thang; N K Hoa; C G Ostenson
Journal:  J Nutr Metab       Date:  2013-01-31

4.  Antidiabetic activity and phytochemical screening of extracts of the leaves of Ajuga remota Benth on alloxan-induced diabetic mice.

Authors:  Tadesse Bekele Tafesse; Ariaya Hymete; Yalemtsehay Mekonnen; Mekuria Tadesse
Journal:  BMC Complement Altern Med       Date:  2017-05-02       Impact factor: 3.659

5.  Evaluation of In Vivo Antidiabetic, In Vitro α-Amylase Inhibitory, and In Vitro Antioxidant Activity of Leaves Crude Extract and Solvent Fractions of Bersama abyssinica Fresen (Melianthaceae).

Authors:  Zemene Demelash Kifle; Engidaw Fentahun Enyew
Journal:  J Evid Based Integr Med       Date:  2020 Jan-Dec

6.  Prevalence and associated factors of herbal medicine use among adult diabetes mellitus patients at government hospital, Ethiopia: An institutional-based cross-sectional study.

Authors:  Zemene Demelash Kifle; Biruk Bayleyegn; Tesfaye Yimer Tadesse; Alem Endeshaw Woldeyohanins
Journal:  Metabol Open       Date:  2021-08-26

Review 7.  Pharmacological evaluation of medicinal plants with antidiabetic activities in Ethiopia: A review.

Authors:  Zemene Demelash Kifle; Mohammedbrhan Abdelwuhab; Abreham Degu Melak; G/Mariam Genet; Tesfaye Meseret; Meaza Adugna
Journal:  Metabol Open       Date:  2022-03-10

8.  Randomized double-blinded pilot clinical study of the antidiabetic activity of Balanites aegyptiaca and UPLC-ESI-MS/MS identification of its metabolites.

Authors:  Hend Rashad; Fateheya M Metwally; Shahira M Ezzat; Maha M Salama; Adel Hasheesh; Amira Abdel Motaal
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.